Is Botulinum Neurotoxin Type A (BoNT-A) a Novel Therapy for Lower Urinary Tract Symptoms Due to Benign Prostatic Enlargement? A Review of the Literature

Abstract Context The intraprostatic injection of botulinum neurotoxin type A (BoNT-A) is a minimally invasive but still-experimental treatment of lower urinary tract symptoms (LUTS) due to benign prostatic enlargment (BPE) based on an off-label use of the drug. Objective Report the mechanisms of act...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European urology 2008-10, Vol.54 (4), p.765-777
Hauptverfasser:	Oeconomou, Athanassios, Madersbacher, Helmut, Kiss, Gustav, Berger, Thomas J, Melekos, Michael, Rehder, Peter
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Benign prostatic enlargement Botulinum neuro-toxin A Botulinum Toxins, Type A - therapeutic use Disease Models, Animal Humans Intraprostatic injection Lower urinary tract symptoms Male Neurotoxins - therapeutic use Prostatic Hyperplasia - complications Prostatism - drug therapy Prostatism - etiology Review Urology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!